Dublin, Oct. 19, 2017 -- The "Global Advanced Wound Care Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.
In this region, global advanced wound care is projected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.
Some of the major factors driving the growth of advanced wound care market are rising aging population, growing incidences of diabetes, technological advancement.
Scope of the Report
- Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing. In 2017, film dressing segment is expected to dominate the global advanced wound care market.
- Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.
- Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).
- Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies.
- Based on NPWT type, the market is segmented into stand-alone NPWT devices, portable NPWT devices and disposable NPWT devices.
- Based on PRD type, the market is segmented into mattress and bed.
- Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.
- Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.
- Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.
- Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, venous ulcer among others. Diabetic ulcers segment is expected to grow at the highest CAGR of in the forecast period.
- On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
- On the basis of distribution channel the market is segmented into direct tenders, and retails.
Acelity L.P. INC. is going to dominate the Advanced Wound Care market followed by
- 3M
- Advancis Medical
- B.Braun Melsungen AG
- Baxter
- BSN Medical
- Cardinal Health
- Coloplast
- Convatec Inc
- Derma Sciences Inc
- DermaRite Industries LLC
- DeRoyal Industries Inc
- Devon Medical Products
- Ethicon. Inc
- Hollister Inc
- Human Biosciences Inc
- Integra Life Sciences Corporation
- Kinetic Concepts
- Medline Industries
- Medtronic
- Mimedx Group
- Molnlycke Healthcare AB
- MPM Medical Inc
- Organogenesis Inc
- Paul Hartmann Limited
- Smith and Nephew
- Spiracur Inc
- Talley Group
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
3.1. Drivers
3.1.1. Rising Aging and Geriatric Population
3.1.2. Technological Advancement
3.1.3. Government Support
3.1.4. Rising Incidences of Chronic Wound
3.1.5. Increasing Trend
3.2. Restraints
3.2.1. Low Awareness
3.2.2. Slow Growth Rate and Shrinking Market
3.2.3. Complex Regulatory Approval Process
3.2.4. Competition With Other Moist Dressings
3.3. Opportunities
3.3.1. Reimbursement
3.3.2. Mergers and Acquisitions To Expand Business
3.3.3. Unmet Need
3.3.4. Increasing Demand
3.4. Challenge
3.4.1. Shortage of Trained Staff
3.4.2. The Development of Substitute Products
3.5. Key Market Trends and Upcoming Technologies
3.5.1. Smart Dressing Will Push Future Growth
3.5.2. Hydrofiber Has Been the Most Significant Recent Innovation
3.5.3. Alginate Dressing is Expected To Grow Robustly in the Upcoming Years
3.5.4. Foam Dressing Accounting the Largest Market Segment in the Upcoming Years
4. Executive Summary
5. Premium Insights
6. Global Advanced Wound Care Market, by Product Type
6.1. Overview
6.2. Dressing
6.3. Biologics
6.4. Therapy Devices
7. Global Advanced Wound Care Market, by Wound Type
7.1. Introduction
7.2. Surgical Wound
7.2.1. Class I
7.2.2. Class II
7.2.3. Class III
7.2.4. Class IV
7.3. Diabetic Ulcers
7.4. Pressure Ulcers
7.5. Venous Ulcers
7.6. Burns
8. Global Advanced Wound Care Market, by End User
9. Global Advanced Wound Care Market, by Distribution Channel
10. Global Advanced Wound Care Market, by Geography
11. Global Advanced Wound Care Market, Company Share
12. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/7zvslt/global_advanced
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Wound Care


Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



